---------- Forwarded message ----------
From: Nature Publishing Group <naturepublishinggrp@ealert.nature.com>
Date: 2012/2/16
Subject: Autism Spectrum Disorders: From Biological Understanding to Therapeutic Strategies
To: Carlo Hanau <hanau.carlo@gmail.com>


div, p, a, li, td { -webkit-text-size-adjust:none; }
Click here if this e-mail doesn't display properly     
               
                Roche - Nature Medicine
        Translational Neuroscience Symposium 2012
Autism Spectrum Disorders: From Biological Understanding to Therapeutic Strategies                   
                The fourth edition of Roche - Nature Medicine Translational Neuroscience Symposium aims at bringing together the world's most distinguished scientists and academics in the areas of autism and neurodevelopmental disorders to share their latest work with each other and around 40 members of Roche's Neuroscience team. Recent genomic and functional studies have shed light on the pathophysiology of autism. The objectives of this meeting are to discuss these recent advances and to explore how insights from other developmental brain disorders can illuminate our quest to understand the biological basis of autism.           
                April 23-25, 2012
      Roche Forum Buonas, Switzerland
       
       
The application and abstract submission deadline is March 12, 2012.
Visit the conference website for more information and to apply.
Admission to this conference is by application. Complimentary registration will be extended to successful applicants.               
SPEAKERS: Gus Alusi
Patrick Bolton
Thomas Bourgeron
Susan Brookheimer
Randall Carpenter
John Constantino
Jacqueline Crawley
Karl Deisseroth
Evan Eichler
Daniel Geschwind
Alysson Muotri
Declan Murphy Kevin Pelphrey
Martin Raff
Mustafa Sahin
Matthew State
Thomas Sudhof
Mehmet Fatih Yanik
               
        SCIENTIFIC COMMITTEE

   Eva Chmielnicki (Nature Medicine, USA)
Paulo Fontoura
(Roche Neuroscience, Switzerland )
Daniel Geschwind (University of California, Los Angeles School of Medicine, USA)
Anirvan Ghosh (Roche Neuroscience, Switzerland )
Thomas R. Insel (National Institute of Mental Health, National Institutes of Health, USA)
Juan Carlos Lopez (Nature Medicine, USA)
Luca Santarelli (Roche Neuroscience, Switzerland)
Will Spooren (Roche Neuroscience, Switzerland)              

For more information and to register, visit:
www.nature.com/natureconferences/tns2012
Twitter
 
Monthly e-alert

               
                                            
               
                               
As a registered user of Nature Publishing Group's Web sites, our database indicates that you have opted-in to receive product information and special offers. If you no longer wish to receive these e-mails or to discontinue all e-mail services from Nature Publishing Group please update your online account. Modify My Account (Log in to be recognised as a Nature.com registrant).

For further information on technical assistance | print subscriptions | other enquiries.

Nature Publishing Group | Principal offices: London | New York | Tokyo. Worldwide offices: Basingstoke | Boston | Buenos Aires | Delhi | Hong Kong | Madrid | Melbourne | Munich | Paris | San Francisco | Seoul | Washington DC. Macmillan Publishers Limited is a company incorporated in England & Wales under company number 785998 & whose registered office is located at Brunel Road, Houndmills, Basingstoke, Hampshire RG21 6XS. Nature Publishing Group | 75 Varick St Fl 9 | New York | NY 10013-1917 | USA

© 2012 Nature Publishing Group, a division of Macmillan Publishers Limited. All rights reserved.



--
Prof. Carlo Hanau
docente di Statistica medica
e di Programmazione e organizzazione dei servizi sociali e sanitari
Dipartimento di Educazione e Scienze umane
Facoltą di Scienze della Formazione
Universitą di Modena e Reggio Emilia
via Allegri, 9
42121 Reggio Emilia
Universitą di Modena e Reggio Emilia